California State Teachers Retirement System lowered its holdings in shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) by 6.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 91,984 shares of the specialty pharmaceutical company’s stock after selling 6,700 shares during the period. California State Teachers Retirement System owned 0.18% of SciClone Pharmaceuticals worth $1,012,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of SCLN. State of Alaska Department of Revenue grew its holdings in SciClone Pharmaceuticals by 78.9% during the second quarter. State of Alaska Department of Revenue now owns 10,213 shares of the specialty pharmaceutical company’s stock worth $112,000 after purchasing an additional 4,503 shares during the period. Profund Advisors LLC bought a new position in SciClone Pharmaceuticals during the second quarter worth about $113,000. Kassirer Asset Management Corp bought a new position in SciClone Pharmaceuticals during the second quarter worth about $165,000. BNP Paribas Arbitrage SA grew its holdings in SciClone Pharmaceuticals by 54.0% during the second quarter. BNP Paribas Arbitrage SA now owns 16,140 shares of the specialty pharmaceutical company’s stock worth $178,000 after purchasing an additional 5,658 shares during the period. Finally, Cubist Systematic Strategies LLC bought a new position in SciClone Pharmaceuticals during the second quarter worth about $195,000. Institutional investors and hedge funds own 72.80% of the company’s stock.

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) opened at $11.15 on Monday. SciClone Pharmaceuticals, Inc. has a 1-year low of $8.55 and a 1-year high of $11.43.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/11/27/california-state-teachers-retirement-system-has-1-01-million-stake-in-sciclone-pharmaceuticals-inc-scln.html.

About SciClone Pharmaceuticals

SciClone Pharmaceuticals, Inc is a pharmaceutical company. The Company’s product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Company’s business is focused primarily in the People’s Republic of China. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong.

Institutional Ownership by Quarter for SciClone Pharmaceuticals (NASDAQ:SCLN)

Receive News & Stock Ratings for SciClone Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciClone Pharmaceuticals Inc. and related stocks with our FREE daily email newsletter.